Cargando…
Transverse myelitis after anti‐CD19 directed CAR T cell therapy for relapsed large B cell lymphoma
Autores principales: | Sheikh, Semira, Mokhtari, Sepideh, Silverman, Jeffrey A., Reid, Kayla, Faramand, Rawan, Davila, Marco L., Franke, Norman, Locke, Frederick L., Jain, Michael D., Wong, Daniel, Kuruvilla, John G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175700/ https://www.ncbi.nlm.nih.gov/pubmed/35846190 http://dx.doi.org/10.1002/jha2.286 |
Ejemplares similares
-
Relapsed/Refractory Hodgkin Lymphoma
por: Sheikh, Semira, et al.
Publicado: (2018) -
Transverse Myelitis
por: Beh, Shin C., et al.
Publicado: (2013) -
Transverse Myelitis
por: Lim, Peter A.C.
Publicado: (2020) -
Constipation in transverse myelitis
por: Chinnappan, Justine, et al.
Publicado: (2023) -
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion
por: Rejeski, Kai, et al.
Publicado: (2023)